MASI Company Profile and Key Details

Q: Who are the executives of MASI?

Mr. Thomas Samuel McClenahanExecutive Vice President, Gen. Counsel & Corporation Sec.Mr. Tao Leopold LevyExecutive Vice President of Bus. Devel.Mr. Yongsam LeeExecutive Vice President & Chief Information OfficerMr. Micah YoungExecutive Vice President & Chief Financial OfficerMr. Jon ColemanPres of Worldwide Sales, Professional Services & Medical AffairsMr. Anand SampathExecutive Vice President of Operations & Clinical ResearchDr. Steven J. BarkerChairman of Scientific Advisory Board & Chief Science OfficerMr. Paul HataishiSenior Vice President & Chief Accounting OfficerMr. Joseph E. KianiFounder, Chief Executive Officer & ChairmanMr. Bilal MuhsinChief Operating OfficerMr. Eli KammermanVice President of Bus. Devel. & Investor Relations

NASDAQ : MASI

Masimo

$179.95

At Close 4:00 PM

Not Actively Trading

59.55

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Masimo Corporation (MASI) stock remained unchanged at $179.95 a share on NASDAQ. The stock opened at $179.95, fluctuating between $179.95 to $179.95 during the session.

Stock Snapshot

179.95

Prev. Close

9.42B

Market Cap

179.95

Day Low

44.4320987654321

P/E Ratio

4.05

EPS (TTM)

0.12

Cash Flow per Share

179.95

Open

52.37M

Number of Shares

179.95

Day High

85.53%

Free Float in %

25.85

Book Value

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jun 09, 2026	179.95	179.99	179.95	179.95	3.09M
Jun 08, 2026	179.93	179.97	179.90	179.94	1.27M
Jun 05, 2026	178.98	179.00	178.80	178.82	619.62K
Jun 04, 2026	178.72	178.96	178.72	178.90	951.95K
Jun 03, 2026	178.79	178.92	178.63	178.78	842.76K
Jun 01, 2026	178.41	178.72	178.30	178.59	668.47K
May 29, 2026	178.51	178.62	178.38	178.45	824.7K
May 28, 2026	178.58	178.65	178.42	178.45	1.29M
May 27, 2026	178.57	178.80	178.39	178.78	785K
May 26, 2026	178.69	178.78	178.51	178.67	909.41K
May 22, 2026	178.68	178.84	178.36	178.81	677.26K
May 21, 2026	178.79	178.88	178.60	178.64	1.18M
May 20, 2026	178.89	178.89	178.65	178.79	745.7K
May 19, 2026	178.76	178.94	178.51	178.80	730.07K
May 18, 2026	178.49	178.94	178.36	178.80	1.58M
May 15, 2026	178.45	178.51	178.35	178.47	662.23K
May 14, 2026	178.45	178.45	178.33	178.35	578.97K
May 13, 2026	178.65	178.67	178.28	178.41	746.03K
May 12, 2026	178.65	178.65	178.48	178.55	823.71K
May 11, 2026	178.35	178.75	178.31	178.50	826.62K

Contact Details

Irvine, CA 92618

United States

https://www.masimo.com 949 297 7000

About Company

Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Stock Peers

SWAV

-0.08-0.02%

ShockWave Medical, Inc.$334.75 UFPT

2.14+0.69%

UFP Technologies, Inc.$314.01 ALGN

4.58+2.71%

Align Technology, Inc.$173.66 PODD

1.87+1.34%

Insulet Corp.$141.17 IRTC

-0.28-0.22%

iRhythm Technologies, Inc.$127.84 IRMD

1.285+1.41%

IRadimed Corporation$92.50 DXCM

1.73+2.08%

DexCom, Inc.$84.75 TMDX

3.68+4.59%

TransMedics Group, Inc.$83.89 NARI

Inari Medical, Inc.$79.97 ESTA

-1.63-2.06%

Establishment Labs Holdings Inc.$77.42

Company Overview

The stock is currently trading near its 52-week high $125.94 and $179.99. With a market capitalization of about $9.42 billion, Masimo Corporation is classified as a mid-cap and shows market-like volatility (beta ~1.18). Key stats such as the average daily volume over the past year has been around 1.08 million shares, volume is running light vs its 52-week average. Headquartered in Irvine, CA, Masimo Corporation operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Catherine Szyman, the company employs approximately 7,500 people and listed since August 08, 2007. Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide.

Technical Performance

MASI has shown mixed momentum, gaining 7.92% over the past week and -2.78% over the past quarter, though year-to-date performance is up 9.72%. Short-term trend indicators are mixed aligned (SMA20 15.62%, SMA50 23.0%, SMA200 17.31%). The stock’s 14-day RSI is 75.94 (overbought), while the ATR of 4.65 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -10.09% below its high and over 39.13% above its low.

Valuation Metrics

Masimo Corporation trades at a P/E ratio of 124.97, slightly above the S&P 500 average, with a price-to-sales ratio of 6.05 and a price-to-book ratio of 11.91 reflecting a rich premium to book value. The P/FCF stands at 45.13, also above market averages. Compared to sector medians, Masimo Corporation P/S is trading rich, and the P/B is far lower than peers, underscoring the brand and earnings power premium investors assign to the stock.

Dividend & Fair Value

Masimo Corporation last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $47.40. This means the shares are trading above this model’s fair value.

Earnings & Analyst Outlook

Wall Street analysts project EPS growth of 14.56% annually over the next five years. The latest quarter delivered EPS of $1.10. The next quarter is forecast at $1.48. Next year's EPS is expected at $5.78. Analyst sentiment is bullish. Analyst rating data shows there are 1 Strong Buy ratings, 4 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $200.00 to $162.00. The high target offers 11.14% upside. The low target suggests -9.97% downside. The mean target is $190.43. This offers 5.82% upside. Masimo Corporation earnings surprise history is a mixed track record. The quarter that ended May 05, 2026, missed forecasts by -21.99%. The prior quarter beat by -87.84%. Over the last six quarters, Apple has recorded several small beats. These include 26.76% in February 25, 2025.

Shareholding & Insider Activity

Masimo Corporation has 54.32 million shares outstanding. The public float is 46.46 million shares, elevated short interest at 10.98% of float. This equals 4.11 million shares. The short ratio is 5.19 days. Institutional investors hold 111.73% of the float. Insiders own 6.21%. KIANI JOE E holds 363.29 thousand shares, Lee Yongsam has 75.00 thousand shares and Barker Steven has 66.24 thousand shares.

Financial & Profitability Overview

Over the trailing twelve months, Masimo generated $2.05B in revenue, or $37.86 per share. Gross margin was 49.00%, operating margin 8.02%, and net profit margin 3.98%. Returns are modest, with ROA at 2.68% and ROE at 5.97%.
On valuation metrics, Masimo trades at a P/E of 124.97, P/S of 6.05 and P/B of 11.91. The current ratio is 2.68 and quick ratio is 1.45. Operationally, the company’s inventory turnover is 1.49 and cash conversion cycle is 257.96 days. Debt-to-equity is 0.62, supported by a cash flow-to-debt ratio of 0.48.

Quarterly Financial Highlights

For the quarter ended Dec 30, 2023, Masimo posted revenue of $2.05B, down slightly from $2.04B in the prior quarter. Gross profit was $1.00B (margin 49.00%). Operating income was $164.30M (margin 8.0%). Net income was$81.50M (EPS $1.54).
The company ended the quarter with $166.00M in cash and short-term investments, a total debt of $970.00M, and net debt of $804.00M. Total assets were $3.04B, with equity of $1.36B. Financials further reflected stability, with operating cash flow of $94.10M, free cash flow of $6.40M, and capital expenditures of - $87.70M.

Price Forecast & Outlook

Our AI price prediction model suggests that Masimo Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.46%, with price expected at $180.77 by June 23, 2026, within a range of $174.13 to $188.11 3-Month Outlook: Projected rise of 6.85%, reaching $192.28 by September 07, 2026, with a range of $186.48 to $199.47. 1-Year Outlook: Projected gain of 10.64%, with price at $199.09 by June 09, 2027, within a range of $188.95 to $207.01.

Key Takeaways

Masimo Corporation (NASDAQ:MASI) shares are flat 9.72% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Masimo Corporation trading at a premium to the broader market with a P/E of 124.97. Analyst sentiment is cautious, with the majority of ratings in Equal-Weight territory and a mean price target of $168.52, suggesting -6.35% downside. Our AI forecast model points to short-term strength (0.46% over two weeks), a medium-term rise (6.85% over three months), and a longer-term gain (10.64% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Masimo Corporation (MASI) stock price?

Masimo Corporation (NASDAQ: MASI) stock price is $179.95 in the last trading session. During the trading session, MASI stock reached the peak price of $179.95 while $179.95 was the lowest point it dropped to. The percentage change in MASI stock occurred in the recent session was 0% while the dollar amount for the price change in MASI stock was $0.00.

MASI's industry and sector of operation?

The NASDAQ listed MASI is part of Medical - Devices industry that operates in the broader Healthcare sector. Masimo Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of MASI?

Mr. Thomas Samuel McClenahan
Executive Vice President, Gen. Counsel & Corporation Sec.
Mr. Tao Leopold Levy
Executive Vice President of Bus. Devel.
Mr. Yongsam Lee
Executive Vice President & Chief Information Officer
Mr. Micah Young
Executive Vice President & Chief Financial Officer
Mr. Jon Coleman
Pres of Worldwide Sales, Professional Services & Medical Affairs
Mr. Anand Sampath
Executive Vice President of Operations & Clinical Research
Dr. Steven J. Barker
Chairman of Scientific Advisory Board & Chief Science Officer
Mr. Paul Hataishi
Senior Vice President & Chief Accounting Officer
Mr. Joseph E. Kiani
Founder, Chief Executive Officer & Chairman
Mr. Bilal Muhsin
Chief Operating Officer
Mr. Eli Kammerman
Vice President of Bus. Devel. & Investor Relations

How MASI did perform over past 52-week?

MASI's closing price is 42.89% higher than its 52-week low of $125.94 where as its distance from 52-week high of $179.99 is -0.02%.

How many employees does MASI have?

Number of MASI employees currently stands at 7,500.

Link for MASI official website?

Official Website of MASI is: https://www.masimo.com

How do I contact MASI?

MASI could be contacted at phone 949 297 7000 and can also be accessed through its website. MASI operates from 52 Discovery, Irvine, CA 92618, United States.

How many shares of MASI are traded daily?

MASI stock volume for the day was 0 shares. The average number of MASI shares traded daily for last 3 months was 1.08M.

What is the market cap of MASI currently?

The market value of MASI currently stands at $9.42B with its latest stock price at $179.95 and 52.37M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	7500
Beta	1.18
Sales or Revenue	$2.05B
5Y Sales Change%	1.533%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices

MASI Company Profile and Key Details

Masimo

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Earnings & Analyst Outlook

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Key Takeaways

Price Forecast & Outlook

Valuation Metrics